MedVellum
MedVellum
Back to Library
Rheumatology
Orthopaedics
Geriatrics
Emergency Medicine

Pseudogout

High EvidenceUpdated: 2025-12-22

On This Page

Red Flags

  • Suspected septic arthritis (clinically indistinguishable — MUST aspirate)
  • Fever with monoarthritis
  • Immunocompromised patient with joint pain
  • Post-procedural joint pain/swelling
  • Failure to respond to appropriate treatment
Overview

Pseudogout

1. Topic Overview

Summary

Pseudogout is an acute crystal arthropathy caused by deposition of calcium pyrophosphate dihydrate (CPPD) crystals in articular cartilage and subsequent release into joint fluid. Unlike gout (monosodium urate crystals), pseudogout primarily affects older patients and classically involves the knee or wrist. The condition is clinically indistinguishable from septic arthritis and gout, making joint aspiration essential for diagnosis. Radiographic chondrocalcinosis (cartilage calcification) is highly supportive but not diagnostic.

Key Facts

  • Definition: Acute inflammatory arthritis caused by CPPD crystal deposition
  • Prevalence: Increases with age; 15-30% of elderly have radiographic chondrocalcinosis
  • Key Joints: Knee (50%), wrist (30%), shoulders, ankles, elbows
  • Crystal Features: Weakly positively birefringent rhomboid crystals (vs gout: negative needle)
  • Radiographic Sign: Chondrocalcinosis — linear calcification in fibrocartilage and hyaline cartilage
  • "3 H's": Associated with Hyperparathyroidism, Haemochromatosis, Hypomagnesaemia

Clinical Pearls

Blue = Positive = Pseudogout: Under polarised microscopy, CPPD crystals are rhomboid and weakly POSITIVELY birefringent (blue when parallel to compensator). Gout = negative needle (yellow when parallel).

Always Aspirate: Acute monoarthritis in an elderly patient is septic arthritis until proven otherwise. You CANNOT distinguish pseudogout from septic arthritis clinically — aspiration is mandatory.

Young Pseudogout = Metabolic Screen: CPPD disease in patients <55 years should prompt investigation for underlying metabolic causes: calcium, magnesium, ferritin, and parathyroid hormone.

Why This Matters Clinically

Pseudogout is a common cause of acute joint pain in elderly patients and is frequently encountered in hospital medicine. The critical clinical issue is distinguishing it from septic arthritis, which requires joint aspiration. Missing septic arthritis can lead to joint destruction, sepsis, and death.


2. Epidemiology

Incidence & Prevalence

  • Radiographic Chondrocalcinosis: 15-30% of people >70 years; 50% of people >90 years
  • Symptomatic CPPD: Much less common; most chondrocalcinosis is asymptomatic
  • Trend: Increasing with ageing population

Demographics

FactorDetails
AgeRare <55 years; prevalence increases dramatically with age
SexEqual male:female (unlike gout which is male-predominant)
EthnicityNo significant differences
GeographyHigher prevalence in regions with hereditary forms (e.g., Chile, Slovakia)

Risk Factors

Non-Modifiable:

  • Advanced age (strongest factor)
  • Family history (hereditary CPPD exists)
  • Previous joint injury or surgery
  • Pre-existing OA (CPPD deposits in damaged cartilage)

Modifiable/Metabolic:

ConditionMechanismScreening Test
HyperparathyroidismHypercalcaemia promotes crystal formationCalcium, PTH
HaemochromatosisIron overload, inhibits pyrophosphatasesFerritin, transferrin saturation
HypomagnesaemiaLow Mg increases pyrophosphate solubilitySerum magnesium
HypophosphataemiaPhosphate metabolism disruptionPhosphate
HypothyroidismUnclear mechanismTFTs

Mnemonic: "The 3 H's": Hyperparathyroidism, Haemochromatosis, Hypomagnesaemia


3. Pathophysiology

Mechanism

Step 1: Crystal Formation

  • CPPD crystals form in cartilage matrix (particularly fibrocartilage)
  • Favoured by high pyrophosphate concentration and appropriate calcium levels
  • Deposits in menisci, TFCC, symphysis pubis, intervertebral discs

Step 2: Crystal Shedding ("Flare Trigger")

  • Acute illness, surgery, trauma, or metabolic change
  • Crystals shed from cartilage into synovial fluid
  • Partial dissolution changes crystal surface properties

Step 3: Inflammatory Response

  • CPPD crystals activate NLRP3 inflammasome in synovial macrophages
  • IL-1β and IL-18 release → intense inflammation
  • Neutrophil recruitment → acute synovitis

Step 4: Resolution

  • Self-limiting over days to weeks
  • Crystals may re-deposit or persist in fluid
  • Recurrent attacks contribute to joint damage

Classification (Phenotypes)

PhenotypeClinical FeaturesJoints
Acute CPP Crystal ArthritisSudden onset, mimics gout/septicKnee, wrist most common
Chronic CPP Crystal Inflammatory ArthritisRA-like polyarthritisMultiple joints
OA with CPPDOA with superimposed acute attacksKnees, hips, MCPs
Pseudo-NeuropathicSevere joint destructionShoulder, knee
Asymptomatic ChondrocalcinosisIncidental finding on X-rayAny

Anatomical Considerations

  • Knee: Meniscal calcification; most common site of acute attacks
  • Wrist: Triangular fibrocartilage (TFCC) calcification
  • Symphysis pubis: Classic site of chondrocalcinosis on AP pelvis X-ray
  • Cervical spine: Crowned dens syndrome (atlantoaxial calcification)

4. Clinical Presentation

Symptoms

Typical Presentation:

Atypical Presentations:

Signs

Red Flags

[!CAUTION] Red Flags — Aspirate urgently and consider septic arthritis if:

  • High fever (>38.5°C) or rigors
  • Immunocompromised patient (diabetes, steroids, HIV)
  • Prosthetic joint
  • Post-procedural (after injection or surgery)
  • Failure to improve with appropriate treatment
  • Overlying skin infection

Acute onset severe joint pain (hours) — 95%
Common presentation.
Swelling, warmth, erythema — 90%
Common presentation.
Preceding trigger (illness, surgery) — 50%
Common presentation.
Limited range of motion — 85%
Common presentation.
Systemic symptoms (low-grade fever, malaise) — common
Common presentation.
5. Clinical Examination

Structured Approach

General:

  • Assess for systemic illness (fever, tachycardia)
  • Look for features of metabolic causes (skin bronzing = haemochromatosis)
  • Check other joints (polyarticular involvement)

Joint Examination:

  • Inspect for swelling, erythema
  • Palpate for warmth, effusion, tenderness
  • Assess active and passive range of motion
  • Check for instability or crepitus

Special Tests

TestTechniquePositive FindingSignificance
Joint AspirationSterile aspiration of synovial fluidInflammatory fluid + CPPD crystalsDIAGNOSTIC
Polarised MicroscopyExamine fluid under polarised lightWeakly +ve birefringent rhomboidsConfirms CPPD
Effusion AssessmentPatellar tap, ballottementFluid presentIndication for aspiration
ROM AssessmentActive/passive movementPain-limited, guardingNon-specific

6. Investigations

First-Line (Bedside)

  • Joint aspiration — ESSENTIAL FOR DIAGNOSIS
  • Temperature, HR, BP — assess for sepsis

Laboratory Tests

TestExpected FindingPurpose
Synovial Fluid WBC10,000-50,000/μL (inflammatory)Differentiate from non-inflammatory
Synovial Fluid CrystalsCPPD: rhomboid, weakly +ve birefringentDIAGNOSTIC
Gram Stain & CultureNegative (excludes sepsis)MUST do on every aspirate
CRP/ESRElevated; non-specificMonitor inflammation
FBCElevated WCC possibleNon-specific
UrateNormal (rules out gout)Differential diagnosis

Metabolic Screen (if young or polyarticular):

  • Calcium, PTH — hyperparathyroidism
  • Ferritin, transferrin saturation — haemochromatosis
  • Magnesium — hypomagnesaemia
  • TFTs — hypothyroidism
  • Phosphate — hypophosphataemia

Imaging

ModalityFindingsIndication
X-rayChondrocalcinosis (linear cartilage calcification)Supporting diagnosis
UltrasoundHyperechoic deposits in cartilageSensitive for chondrocalcinosis
CTCalcification detail; crowned densCervical spine symptoms
MRISynovitis, effusion, cartilageComplex cases

X-ray Chondrocalcinosis Sites

  • Knee menisci (most common)
  • Triangular fibrocartilage of wrist
  • Symphysis pubis
  • Intervertebral discs
  • Achilles tendon insertion

7. Management

Management Algorithm

ACUTE PSEUDOGOUT MANAGEMENT
              ↓
┌─────────────────────────────────────────────────┐
│             FIRST-LINE OPTIONS                  │
│          (Choose based on patient)              │
│                                                 │
│ • Intra-articular corticosteroid (preferred)    │
│   - Methylprednisolone 40mg or Triamcinolone    │
│   - Immediate relief; ideal for single joint    │
│                                                 │
│ • NSAIDs (if no contraindications)              │
│   - Naproxen 500mg BD or Indomethacin 50mg TDS  │
│   - Avoid in CKD, GI bleeding, CCF, elderly     │
│                                                 │
│ • Colchicine (alternative)                      │
│   - 500mcg BD-TDS                               │
│   - Watch for GI side effects                   │
│   - Reduce dose in CKD                          │
└─────────────────────────────────────────────────┘
              ↓
      If Multiple Joints or Contraindications:
              ↓
┌─────────────────────────────────────────────────┐
│           SYSTEMIC CORTICOSTEROIDS              │
│                                                 │
│ • Prednisolone 30-40mg daily, taper over 7-14d  │
│ • IM methylprednisolone if oral not possible    │
└─────────────────────────────────────────────────┘
              ↓
              PROPHYLAXIS (Recurrent Attacks)
              ↓
              Low-dose colchicine 500mcg OD-BD

Acute/Emergency Management

Immediate Actions:

  1. Joint aspiration — diagnostic and therapeutic (draining inflammatory fluid reduces pressure)
  2. Send fluid for microscopy, Gram stain, culture
  3. Initiate treatment once sepsis excluded

Conservative Management

  • Ice application to affected joint
  • Rest and elevation
  • Avoid weight-bearing if lower limb affected

Medical Management

Drug ClassDrugDoseNotes
Intra-articular steroidMethylprednisolone40-80mgFirst-line for single joint
NSAIDsNaproxen500mg BD for 7-10 daysAvoid in elderly, CKD, CVD
NSAIDsIndomethacin50mg TDS for 7-10 daysGI protection with PPI
ColchicineColchicine500mcg BD-TDSAlternative; GI side effects
Systemic steroidsPrednisolone30-40mg OD, taperingPolyarticular or contraindications
ProphylaxisColchicine500mcg OD-BDFor recurrent attacks

Chronic/Recurrent Disease

  • No disease-modifying therapy available (unlike gout)
  • Prophylactic colchicine reduces attack frequency
  • Magnesium supplementation may help if deficient
  • Treat underlying metabolic cause if identified

Disposition

  • Admit if: Septic arthritis not excluded, systemic illness, unable to take oral meds
  • Discharge if: Sepsis excluded, can take oral treatment, close follow-up arranged
  • Follow-up: GP/Rheumatology in 1-2 weeks; metabolic screen if indicated

8. Complications

Immediate (Minutes-Hours)

ComplicationIncidencePresentationManagement
Missed septic arthritisAvoidableWorsening sepsisUrgent repeat aspiration, IV antibiotics
Haemarthrosis (post-aspiration)RareWorsening swellingPressure, may need drainage

Early (Days)

  • Treatment failure: Consider alternative diagnosis or resistant case
  • NSAID complications: GI bleeding, AKI, CCF exacerbation
  • Colchicine toxicity: Diarrhoea, myopathy (especially with CKD)

Late (Weeks-Months)

  • Recurrent attacks: Common; consider prophylaxis
  • Chronic arthropathy: Progressive joint damage with repeated attacks
  • Secondary OA: Accelerated by CPPD deposition
  • Rare destructive arthropathy: Pseudo-neuropathic joint (shoulders, knees)

9. Prognosis & Outcomes

Natural History

Acute attacks are self-limiting, typically resolving over 1-3 weeks even without treatment. Recurrence is common. Chronic CPPD deposition contributes to joint degeneration over time. Unlike gout, there is no curative treatment — management is symptomatic.

Outcomes with Treatment

VariableOutcome
Acute attack resolution1-2 weeks with treatment
RecurrenceCommon; 50% have recurrent attacks
Joint damageProgressive with recurrent attacks
MortalityNot directly fatal; acute attacks may indicate underlying illness

Prognostic Factors

Good Prognosis:

  • Single joint involvement
  • Responsive to treatment
  • No underlying metabolic cause
  • Infrequent attacks

Poor Prognosis:

  • Recurrent attacks
  • Polyarticular disease
  • Underlying metabolic disorder (if untreated)
  • Severe joint damage at presentation

10. Evidence & Guidelines

Key Guidelines

  1. EULAR (2011) — Recommendations for diagnosis and management of CPPD. Emphasise aspiration for diagnosis; intra-articular steroid as first-line for acute attacks.

  2. ACR/EULAR (2015 Updates) — Support colchicine for prophylaxis in recurrent disease; recommend metabolic screening in young patients.

Landmark Studies

McCarty & Hollander (1961) — Original description of CPPD crystals

  • First identified CPPD as distinct from urate crystals
  • Clinical Impact: Established pseudogout as separate entity from gout

Zhang et al. (2011) — EULAR systematic review

  • Comprehensive review of CPPD diagnosis and management
  • Key finding: Intra-articular corticosteroids effective; no disease-modifying therapy
  • Clinical Impact: Established evidence-based management recommendations

Rosenthal & Ryan (2016) — Pathogenesis review

  • Elucidated role of NLRP3 inflammasome in CPPD inflammation
  • Clinical Impact: Explains why IL-1 inhibitors may work in refractory cases

Evidence Strength

InterventionLevelKey Evidence
Intra-articular corticosteroid1bRCTs, EULAR recommendations
NSAIDs2aExtrapolated from gout trials
Colchicine (acute)2bCohort studies, expert consensus
Colchicine (prophylaxis)2bObservational studies

11. Patient/Layperson Explanation

What is Pseudogout?

Pseudogout is a condition where crystals build up in your joint cartilage and then suddenly cause intense pain and swelling. These crystals are made of calcium pyrophosphate (different from the uric acid crystals in regular gout). It's called "pseudo" (meaning false) gout because it causes very similar symptoms to gout but needs different treatment.

Why does it matter?

Pseudogout attacks can be extremely painful and make it hard to walk or use the affected joint. The main concern is that it looks exactly like a joint infection (septic arthritis), which is very serious. That's why doctors usually need to take a small sample of fluid from your joint to check for crystals and infection.

How is it treated?

  1. Draining the joint: Taking fluid out provides immediate relief and allows testing to confirm the diagnosis.

  2. Steroid injection: An injection into the joint is often the best treatment for a single swollen joint.

  3. Anti-inflammatory tablets: NSAIDs (like ibuprofen or naproxen) or colchicine can reduce inflammation.

  4. Steroids tablets: If the injection isn't suitable, steroid tablets work well.

  5. No cure: Unlike gout, there's no treatment that removes the crystals permanently. Treatment focuses on managing attacks when they happen.

What to expect

  • Attacks usually settle within 1-2 weeks with treatment
  • You may have future attacks — this is normal
  • If attacks are frequent, a daily low-dose medication can reduce them

When to seek help

See a doctor urgently if:

  • You have sudden severe joint pain with swelling
  • You have a fever with joint pain
  • You recently had a joint injection or surgery
  • The joint becomes red and hot

12. References

Primary Guidelines

  1. Zhang W, Doherty M, Bardin T, et al. European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis. 2011;70(4):563-570. PMID: 21216817

Key Trials

  1. Zhang W, Doherty M, Pascual E, et al. EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis. 2011;70(4):571-575. PMID: 21257615

  2. Rosenthal AK, Ryan LM. Calcium Pyrophosphate Deposition Disease. N Engl J Med. 2016;374(26):2575-2584. PMID: 27355536

  3. McCarthy DJ, Hollander JL. Identification of urate crystals in gouty synovial fluid. Ann Intern Med. 1961;54:452-460. PMID: 13773775

Further Resources

  • American College of Rheumatology: rheumatology.org
  • Radiopaedia — Chondrocalcinosis examples


Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate guidelines and specialists for patient care.

Last updated: 2025-12-22

At a Glance

EvidenceHigh
Last Updated2025-12-22

Red Flags

  • Suspected septic arthritis (clinically indistinguishable — MUST aspirate)
  • Fever with monoarthritis
  • Immunocompromised patient with joint pain
  • Post-procedural joint pain/swelling
  • Failure to respond to appropriate treatment

Clinical Pearls

  • **Young Pseudogout = Metabolic Screen**: CPPD disease in patients &lt;55 years should prompt investigation for underlying metabolic causes: calcium, magnesium, ferritin, and parathyroid hormone.
  • Mnemonic: **"The 3 H's"**: **H**yperparathyroidism, **H**aemochromatosis, **H**ypomagnesaemia
  • **Red Flags** — Aspirate urgently and consider septic arthritis if:
  • - High fever (&gt;38.5°C) or rigors
  • - Immunocompromised patient (diabetes, steroids, HIV)

Guidelines

  • NICE Guidelines
  • BTS Guidelines
  • RCUK Guidelines